179 related articles for article (PubMed ID: 2576232)
21. [Pharmacological correction of traumatic brain edema].
Novikov VE; Iasnetsov VS
Farmakol Toksikol; 1984; 47(1):34-7. PubMed ID: 6142833
[TBL] [Abstract][Full Text] [Related]
22. [The mediator mechanisms of the ventral hippocampus in anxiety states formed by different aversive exposures].
Talalaenko AN; Krivobok GK; Stakhovskiĭ IuV; Chernikov AV; Shekhovtsov AA; Shevchenko SL
Biull Eksp Biol Med; 1992 Oct; 114(10):374-6. PubMed ID: 1363197
[TBL] [Abstract][Full Text] [Related]
23. [Neurochemical characteristics of the ventromedial hypothalamus and anti-aversive effects of anxiolytic agents in various anxiety models].
Talalaenko AN; Pankrat'ev DV; Goncharenko NV
Ross Fiziol Zh Im I M Sechenova; 2001 Sep; 87(9):1217-26. PubMed ID: 11763535
[TBL] [Abstract][Full Text] [Related]
24. Neurochemical characteristics of the ventromedial hypothalamus in mediating the antiaversive effects of anxiolytics in different models of anxiety.
Talalaenko AN; Pankrat'ev DV; Goncharenko NV
Neurosci Behav Physiol; 2003 Mar; 33(3):255-61. PubMed ID: 12762592
[TBL] [Abstract][Full Text] [Related]
25. Serotoninergic control of punished behavior: effects of intra-raphe microinjections of chlordiazepoxide, GABA and 5-HT on behavioral suppression in rats.
Soubrié P; Thiébot MH; Jobert A; Hamon M
J Physiol (Paris); 1981; 77(2-3):449-53. PubMed ID: 7288658
[TBL] [Abstract][Full Text] [Related]
26. Anxiolytic and anxiogenic beta-carbolines: tools for the study of anxiety mechanisms.
Stephens DN; Kehr W; Duka T
Adv Biochem Psychopharmacol; 1986; 41():91-106. PubMed ID: 2874697
[No Abstract] [Full Text] [Related]
27. [Monoaminergic and aminoacidergic mechanisms of the posterior hypothalamus in realization of the antiaversive effects of anxiosedative and anxioselective agents in various anxiety models].
Talalaenko AN; Pankrat'ev DV; Goncharenko NV
Eksp Klin Farmakol; 2002; 65(5):22-6. PubMed ID: 12596508
[TBL] [Abstract][Full Text] [Related]
28. [Action of beta-carboline derivatives on the evoked activity of hippocampal neurons].
Glushankov PG; Pliashkevich IuG; Skrebitskiĭ VG; Demushkin VP
Biull Eksp Biol Med; 1984 Aug; 98(8):211-3. PubMed ID: 6147169
[TBL] [Abstract][Full Text] [Related]
29. Limbic mechanisms of anxiolytics acting on 5-HT receptors.
Płaźnik A; Kostowski W; Stefański R
Pol J Pharmacol; 1994; 46(5):473-7. PubMed ID: 7894537
[TBL] [Abstract][Full Text] [Related]
30. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.
Cryan JF; Kelly PH; Chaperon F; Gentsch C; Mombereau C; Lingenhoehl K; Froestl W; Bettler B; Kaupmann K; Spooren WP
J Pharmacol Exp Ther; 2004 Sep; 310(3):952-63. PubMed ID: 15113848
[TBL] [Abstract][Full Text] [Related]
31. The GABA-ergic system: a locus of benzodiazepine action.
Tallman JF; Gallager DW
Annu Rev Neurosci; 1985; 8():21-44. PubMed ID: 2858999
[No Abstract] [Full Text] [Related]
32. The anxiolytic activity of beta-carboline derivatives in mice, and its separation from ataxic properties.
Stephens DN; Kehr W; Wachtel H; Schmiechen R
Pharmacopsychiatry; 1985 Jan; 18(1):167-70. PubMed ID: 2859620
[No Abstract] [Full Text] [Related]
33. [The mechanism of action of benzodiazepine and its consequences for therapy].
Cugurra F
Clin Ter; 1992 Apr; 140(4):331-43. PubMed ID: 1350239
[TBL] [Abstract][Full Text] [Related]
34. [Role of benzodiazepine receptors in realizing the anxiolytic effect of compounds on intact rats and on animals with a physical dependence ethanol].
Burov IuV; Orekhov SN; Iukhananov RIu; Vedernikova NN
Biull Eksp Biol Med; 1986 Feb; 101(2):170-2. PubMed ID: 2868765
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of gamma-aminobutyric acid binding by the anxiolytic beta-carbolines ZK 93423 and ZK 91296.
Corda MG; Giorgi O; Longoni B; Mereu GP; Biggio G
J Neurochem; 1987 May; 48(5):1355-8. PubMed ID: 2881979
[TBL] [Abstract][Full Text] [Related]
36. Anxiolytic-like effects and safety profile of a tryptic hydrolysate from bovine alpha s1-casein in rats.
Messaoudi M; Lalonde R; Schroeder H; Desor D
Fundam Clin Pharmacol; 2009 Jun; 23(3):323-30. PubMed ID: 19453759
[TBL] [Abstract][Full Text] [Related]
37. Picrotoxin blocks the anxiolytic- and panicolytic-like effects of sodium valproate in the rat elevated T-maze.
Dombrowski PA; Fernandes LH; Andreatini R
Eur J Pharmacol; 2006 May; 537(1-3):72-6. PubMed ID: 16626689
[TBL] [Abstract][Full Text] [Related]
38. [The role of monoamin- and acidergic mechanisms of the hippocampus in anxiety states of different origins and their participation in the antiaversive effects of anxiolytics].
Talalaenko AN; Krivobok GK; Stakhovskiĭ IuV
Fiziol Zh Im I M Sechenova; 1993 Jan; 79(1):99-104. PubMed ID: 8100168
[TBL] [Abstract][Full Text] [Related]
39. [The GABA-ergic component of the anxiolytic action of 1-(2-pyrimidinyl)-piperazine derivatives].
Abramets II; Talalaenko AN; Stakhovskiĭ IuV
Eksp Klin Farmakol; 1992; 55(6):5-7. PubMed ID: 1363956
[TBL] [Abstract][Full Text] [Related]
40. Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphé reveals differential GABAergic control in two animal tests of anxiety.
Gonzalez LE; Ouagazzal AM; File SE
Eur J Neurosci; 1998 Dec; 10(12):3673-80. PubMed ID: 9875346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
